Rapid identification of new drugs through online monitoring tools The case of NBOMe drugs Dr Monica J. Barratt Research Fellow, NDRI, Melbourne 0407 778 938 [email protected] @monicabarratt
May 15, 2015
Rapid identification of new drugs through online monitoring tools
The case of NBOMe drugs
Dr Monica J. BarrattResearch Fellow, NDRI, Melbourne
0407 778 [email protected]@monicabarratt
The challenge
• New drugs are rapidly emerging• Survey research: months to years. if ever…• Secondary data: 1 to 3 years! if ever…• Can we better harness internet technologies to
monitor new drugs in real-time?
Real-time online monitoring
• What is happening here, right now?• Four tools I will demonstrate today:– Google trends– Bluelight.ru (drug user forum)– Twitter– Silk Road (online drug marketplace)
Example: NBOMe drugs
• Classical hallucinogens• Structurally similar to 2C-x class– E.g. 25i-NBOMe related to 2C-I
• Potency: microgram dosage, on blotters• Availability: easily sent in the post• Legality: analogue laws likely applicable • Public health: associated deaths and serious
incidents reported in media; scant other published research
1. Google Trends
2. Forum (Bluelight.ru)
3. Twitter
4. Silk Road
Summary
• Real-time data on 25x-NBOMe (25 April, 2013)1. Google Trends: search trend increasing in AU2. Bluelight: sold in AU as is & as LSD; use reports3. Twitter: no discussions in AU4. Silk Road: available at high potency and low price
to AU customers
Limitations
• Not representative• Multiple timepoints?• Non-unique or unknown terminology– e.g. National Board of Osteopathic Medical
Examiners • Searching Twitter geographically is restrictive• Information on harms?
Conclusion
• Demand for altered conscious states continues• New drugs are marketed to meet this demand• Freely available online tools can be used to
track new drug use in sentinel groups with no delay
• This information can guide: – our responses, e.g. harm reduction information– additional research via surveys and indicator data